[HTML][HTML] The emerging treatment landscape of targeted therapy in non-small-cell lung cancer

M Yuan, LL Huang, JH Chen, J Wu, Q Xu - Signal transduction and …, 2019 - nature.com
Lung cancer is one of the most common cancer in the world. In 2018, there were over 2
million new cases of lung cancer and over 1.7 million deaths were attributed to lung cancer …

[HTML][HTML] Recent advances in non-small cell lung cancer targeted therapy; an update review

M Araghi, R Mannani, A Heidarnejad maleki… - Cancer Cell …, 2023 - Springer
Lung cancer continues to be the leading cause of cancer-related death worldwide. In the last
decade, significant advancements in the diagnosis and treatment of lung cancer, particularly …

[HTML][HTML] Recent progress in targeted therapy for non-small cell lung cancer

Y Xiao, P Liu, J Wei, X Zhang, J Guo… - Frontiers in Pharmacology, 2023 - frontiersin.org
The high morbidity and mortality of non-small cell lung cancer (NSCLC) have always been
major threats to people's health. With the identification of carcinogenic drivers in non-small …

[HTML][HTML] The emerging treatment landscape of advanced non-small cell lung cancer

P Economopoulou, G Mountzios - Annals of Translational Medicine, 2018 - ncbi.nlm.nih.gov
Lung cancer remains the leading cause of cancer related death worldwide. Despite broad
advances in diagnostics and therapy, the five-year overall survival for patients with …

[HTML][HTML] Biomarker-targeted therapies in non–small cell lung cancer: current status and perspectives

H Guo, J Zhang, C Qin, H Yan, T Liu, H Hu, S Tang… - Cells, 2022 - mdpi.com
Non-small-cell lung cancer (NSCLC) is one of the most common malignancies and the
leading causes of cancer-related death worldwide. Despite many therapeutic advances in …

Therapeutic advances in non‐small cell lung cancer: Focus on clinical development of targeted therapy and immunotherapy

Y Cheng, T Zhang, Q Xu - MedComm, 2021 - Wiley Online Library
Lung cancer still contributes to nearly one‐quarter cancer‐related deaths in the past
decades, despite the rapid development of targeted therapy and immunotherapy in non …

[HTML][HTML] Targeted therapy in advanced non-small cell lung cancer: current advances and future trends

U Majeed, R Manochakian, Y Zhao, Y Lou - Journal of hematology & …, 2021 - Springer
Lung cancer remains the leading cause of cancer-related mortality in both men and women
in the US and worldwide. Non-small cell lung cancer is the most common variety accounting …

Emerging targeted therapies for the treatment of non-small cell lung cancer

PR Halliday, CM Blakely, TG Bivona - Current oncology reports, 2019 - Springer
Abstract Purpose of Review Lung cancer remains the leading cause of cancer-related
mortality worldwide. Genetic and molecular profiling of non-small cell lung cancer (NSCLC) …

[HTML][HTML] Targeted therapies for advanced non-small cell lung cancer

X Ai, X Guo, J Wang, AL Stancu, PMN Joslin, D Zhang… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Lung cancer is a serious health problem and the leading cause of cancer death worldwide,
due to its high incidence and mortality. 85% of lung cancers are represented by the non …

[HTML][HTML] Immunotherapy and targeted therapy for lung cancer: Current status and future perspectives

B Zulfiqar, A Farooq, S Kanwal, K Asghar - Frontiers in Pharmacology, 2022 - frontiersin.org
Lung cancer has the highest incidence of morbidity and mortality throughout the globe. A
large number of patients are diagnosed with lung cancer at the later stages of the disease …